Trial Profile
A Phase III Observer-Blind, Randomized, Controlled, Single-Coordinating Center Pediatric Study in China Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Using a Local Dosing Regimen in Infants.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2013
Price :
$35
*
At a glance
- Drugs TAK 816 (Primary) ; Hib vaccine conjugate
- Indications Haemophilus infections
- Focus Pharmacodynamics
- Sponsors Novartis
- 22 Aug 2013 Results published in the International Journal of Clinical Practice.
- 24 Oct 2011 Actual end date Dec 2010 added as reported by ClinicalTrials.gov.
- 24 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.